The DANAMI @ trial program was designed to investigate @ different randomized treatment strategies in patients with ST-segment elevation myocardial infarction : ( @ ) ischemic postconditioning versus conventional treatment with a primary end point of death and hospitalization for heart failure ; ( @ ) deferring stent implantation in the infarct-related lesion versus conventional treatment with a primary end point of death , hospitalization for heart failure , reinfarction , and repeat revascularization ; and ( @ ) treatment of the culprit lesion only versus fractional flow reserve-guided complete revascularization in patients with multivessel disease , with a primary end point of death , reinfarction , and repeat revascularization .